125 related articles for article (PubMed ID: 3173358)
1. Polar fluorescein derivatives as improved substrate probes for flow cytoenzymological assay of cellular esterases.
Dive C; Cox H; Watson JV; Workman P
Mol Cell Probes; 1988 Jun; 2(2):131-45. PubMed ID: 3173358
[TBL] [Abstract][Full Text] [Related]
2. Improved methodology for intracellular enzyme reaction and inhibition kinetics by flow cytometry.
Dive C; Workman P; Watson JV
Cytometry; 1987 Nov; 8(6):552-61. PubMed ID: 3428040
[TBL] [Abstract][Full Text] [Related]
3. Characterization of uptake and hydrolysis of fluorescein diacetate and carboxyfluorescein diacetate by intracellular esterases in Saccharomyces cerevisiae, which result in accumulation of fluorescent product.
Breeuwer P; Drocourt JL; Bunschoten N; Zwietering MH; Rombouts FM; Abee T
Appl Environ Microbiol; 1995 Apr; 61(4):1614-9. PubMed ID: 7747975
[TBL] [Abstract][Full Text] [Related]
4. Novel dynamic flow cytoenzymological determination of intracellular esterase inhibition by BCNU and related isocyanates.
Dive C; Workman P; Watson JV
Biochem Pharmacol; 1987 Nov; 36(21):3731-8. PubMed ID: 3675627
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of cellular esterases by the antitumour imidazotetrazines mitozolomide and temozolomide: demonstration by flow cytometry and conventional spectrofluorimetry.
Dive C; Workman P; Watson JV
Cancer Chemother Pharmacol; 1989; 25(3):149-55. PubMed ID: 2557170
[TBL] [Abstract][Full Text] [Related]
6. Drug efflux transport properties of 2',7'-bis(2-carboxyethyl)-5(6)-carboxyfluorescein acetoxymethyl ester (BCECF-AM) and its fluorescent free acid, BCECF.
Bachmeier CJ; Trickler WJ; Miller DW
J Pharm Sci; 2004 Apr; 93(4):932-42. PubMed ID: 14999730
[TBL] [Abstract][Full Text] [Related]
7. A comparative study of carboxyfluorescein diacetate and carboxyfluorescein diacetate succinimidyl ester as indicators of bacterial activity.
Hoefel D; Grooby WL; Monis PT; Andrews S; Saint CP
J Microbiol Methods; 2003 Mar; 52(3):379-88. PubMed ID: 12531507
[TBL] [Abstract][Full Text] [Related]
8. A novel in vitro screening assay for trypanocidal activity using the fluorescent dye BCECF-AM.
Obexer W; Schmid C; Brun R
Trop Med Parasitol; 1995 Mar; 46(1):45-8. PubMed ID: 7631128
[TBL] [Abstract][Full Text] [Related]
9. Application of glutaraldehyde for the staining of esterase-active cells with carboxyfluorescein diacetate.
Morono Y; Takano S; Miyanaga K; Tanji Y; Unno H; Hori K
Biotechnol Lett; 2004 Mar; 26(5):379-83. PubMed ID: 15104134
[TBL] [Abstract][Full Text] [Related]
10. Multiparametric analysis of cell membrane permeability by two colour flow cytometry with complementary fluorescent probes.
Dive C; Watson JV; Workman P
Cytometry; 1990; 11(2):244-52. PubMed ID: 2318081
[TBL] [Abstract][Full Text] [Related]
11. In vivo and in vitro evidence for nonrestricted transport of 2',7'-bis(2-carboxyethyl)-5(6)-carboxyfluorescein tetraacetoxymethyl ester at the blood-brain barrier.
Hirohashi T; Terasaki T; Shigetoshi M; Sugiyama Y
J Pharmacol Exp Ther; 1997 Feb; 280(2):813-9. PubMed ID: 9023295
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of intracellular esterases by antitumour chloroethylnitrosoureas. Measurement by flow cytometry and correlation with molecular carbamoylation activity.
Dive C; Workman P; Watson JV
Biochem Pharmacol; 1988 Oct; 37(20):3987-93. PubMed ID: 2973323
[TBL] [Abstract][Full Text] [Related]
13. Use of fluorescent dyes in the determination of adherence of human leucocytes to endothelial cells and the effect of fluorochromes on cellular function.
De Clerck LS; Bridts CH; Mertens AM; Moens MM; Stevens WJ
J Immunol Methods; 1994 Jun; 172(1):115-24. PubMed ID: 8207260
[TBL] [Abstract][Full Text] [Related]
14. Limitations of the fluorescent probe viability assay.
Massaro EJ; Elstein KH; Zucker RM; Bair KW
Mol Toxicol; 1989; 2(4):271-84. PubMed ID: 2490980
[TBL] [Abstract][Full Text] [Related]
15. Analysis of the uptake of the fluorescent marker 2',7'-bis-(2-carboxyethyl)-5(and-6)-carboxyfluorescein (BCECF) by hydrogenosomes in Trichomonas vaginalis.
Scott DA; Docampo R; Benchimol M
Eur J Cell Biol; 1998 Jun; 76(2):139-45. PubMed ID: 9696354
[TBL] [Abstract][Full Text] [Related]
16. Comparison of drug efflux transport kinetics in various blood-brain barrier models.
Bachmeier CJ; Trickler WJ; Miller DW
Drug Metab Dispos; 2006 Jun; 34(6):998-1003. PubMed ID: 16554372
[TBL] [Abstract][Full Text] [Related]
17. Differential effects of two fluorescent probes on macrophage migration as assessed by manual and automated methods.
Denholm EM; Stankus GP
Cytometry; 1995 Apr; 19(4):366-9. PubMed ID: 7796702
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological profile of inhibition of 2',7'-bis(2-carboxyethyl)-5(6)-carboxyfluorescein efflux in human HCT-8 intestinal epithelial cells.
Collington GK; Allen CN; Simmons NL; Hirst BH
Biochem Pharmacol; 1991 Dec; 42 Suppl():S33-8. PubMed ID: 1768283
[TBL] [Abstract][Full Text] [Related]
19. Efflux of bis-carboxyethyl-carboxyfluorescein (BCECF) by a novel ATP-dependent transport mechanism in epithelial cells.
Allen CN; Harpur ES; Gray TJ; Simmons NL; Hirst BH
Biochem Biophys Res Commun; 1990 Oct; 172(1):262-7. PubMed ID: 2222473
[TBL] [Abstract][Full Text] [Related]
20. [FDA-hydrolysis for the fluorometrical evidence of a cell membrane alteration in peritoneal macrophages (author's transl)].
Augsten K; Güttner J
Acta Histochem; 1975; 52(1):79-87. PubMed ID: 809979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
